Related Experiment Video
Updated: May 11, 2026

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells
Published on: August 19, 2016
An enterotoxin-like protein in Staphylococcus aureus strains from patients with toxic shock syndrome
Abstract:
An enterotoxin-like protein, tentatively labeled enterotoxin F, was isolated from Staphylococcus aureus strains taken from patients with toxic shock syndrome. Antibodies specific for enterotoxin F were prepared in rabbits. Use of these antibodies showed that 130 (91.5%) of 142 S. aureus strains from patients with toxic shock syndrome produced enterotoxin F. Strains from toxic shock patients in eight other countries were identified as enterotoxin F producers. Only a small number of S. aureus strains from sources other than patients with toxic shock syndrome were found to produce enterotoxin F. Twenty-one of 111 controls had low antibody titers (less than 1:100) to enterotoxin F whereas 86 of 92 toxic shock patients had low acute phase antibody titers (less than 1:100) to enterotoxin F. Eight of 52 patients had serum conversion as shown by an increase in antibody titer to enterotoxin F in sera taken 21 to 60 days after onset of the illness. It may be possible to identify persons susceptible to toxic shock syndrome by measuring their antibody titer to enterotoxin F.
Insights
A newly identified Staphylococcus aureus toxin, enterotoxin F, is strongly linked to toxic shock syndrome. Measuring antibodies to this toxin may help identify individuals susceptible to the illness.
Area of Science:
- Microbiology
- Immunology
- Infectious Diseases
Background:
- Toxic shock syndrome (TSS) is a severe, life-threatening illness primarily associated with Staphylococcus aureus infections.
- The role of specific toxins produced by S. aureus in the pathogenesis of TSS is crucial for understanding disease mechanisms.
Purpose of the Study:
- To identify and characterize a novel enterotoxin-like protein produced by S. aureus strains from TSS patients.
- To investigate the prevalence of this enterotoxin F in S. aureus isolates from TSS cases globally.
- To evaluate the diagnostic potential of enterotoxin F antibody titers for identifying TSS susceptibility.
Main Methods:
- Isolation and tentative labeling of an enterotoxin-like protein (enterotoxin F) from S. aureus.
- Development of specific antibodies against enterotoxin F in rabbits for immunological detection.
- Screening of S. aureus strains from TSS patients and control groups for enterotoxin F production.
- Measurement of serum antibody titers against enterotoxin F in TSS patients and healthy controls.
Main Results:
- Enterotoxin F was produced by 91.5% of S. aureus strains isolated from TSS patients across multiple countries.
- S. aureus strains from non-TSS sources showed significantly lower rates of enterotoxin F production.
- A high proportion of TSS patients (86/92) exhibited low acute-phase antibody titers to enterotoxin F.
- Serum conversion, indicating an increasing antibody response, was observed in a subset of TSS patients.
Conclusions:
- Enterotoxin F is a key virulence factor strongly associated with Staphylococcus aureus-mediated toxic shock syndrome.
- The high prevalence of enterotoxin F production in TSS-associated strains suggests its significant role in disease pathogenesis.
- Measuring antibody titers to enterotoxin F may serve as a valuable tool for identifying individuals at risk of developing toxic shock syndrome.
More Related Videos
Related Concept Videos
Formation of Lipopolysaccharides
Bacterial Translocation and Protein Secretion
Gram-negative Bacterial Protein Secretion Systems
Bacterial Toxins
Staphylococcal Skin Infections
Bacterial Gastroenteritis

